Glaucoma medications: a drug-therapy review.
Today, clinicians have unprecedented versatility in the treatment of glaucoma. Early detection, prevention, and control are promises inherent in the expansion of the pharmacological glaucoma armamentarium. Choosing the optimal regimen hinges on knowledge about the capabilities and the limitations of currently available medications.
Fiscella
Richard G
RG
University of Illinois at Chicago, Department of Pharmacy Practice, USA.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D016568:Drugs, Generic; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D008916:Miotics / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D016568:Drugs, Generic; D008916:Miotics; D011453:Prostaglandins